Atlassian’s Strong Financial Performance and Optimistic Future Outlook: Price Target Raised to $355
Mizuho Securities analyst Gregg Moskowitz has reiterated their bullish stance on TEAM stock, giving a Buy rating yesterday.Invest with ...
American Association of Individual Investors6d
Why Atlassian Corporation’s (TEAM) Stock Is Up 14.92%
Atlassian Corporation’s TEAM share price has surged by 14.92%, which has investors questioning if this is right time to sell.
Atlassian’s Balanced Outlook: Strong Growth Yet Cautious Valuation Leads to Hold Rating
Atlassian (TEAM – Research Report), the Technology sector company, was revisited by a Wall Street analyst today. Analyst Derrick Wood from TD ...
Atlassian issues upbeat forecasts on strong demand, shares soar
Atlassian on Thursday projected third-quarter revenue above estimates and raised its annual revenue forecast, signaling strong demand for the enterprise software maker's artificial ...
Wells Fargo & Company Issues Positive Forecast for Atlassian (NASDAQ:TEAM) Stock Price
Atlassian (NASDAQ:TEAM – Free Report) had its price target hoisted by Wells Fargo & Company from $350.00 to $375.00 in a ...
Morgan Stanley Forecasts Strong Price Appreciation for Atlassian (NASDAQ:TEAM) Stock
Atlassian (NASDAQ:TEAM – Free Report) had its target price lifted by Morgan Stanley from $315.00 to $370.00 in a research ...
Atlassian Corp. (TEAM): This AI Stock Is On Analysts’ Radars Right Now
Despite DeepSeek and Qwen 2.5 disrupting the global tech sector, investors welcomed the impressive Q4 AI revenues from ...
Atlassian surges on Q2 results as 20% growth appears sustainable
Atlassian shares surged during early market action on Friday after its second quarter fiscal 2025 financial results ...
Le Lézard15h
Qlaris Bio Announces Positive Topline Data From Two Phase II Trials of QLS-111 in Patients With Primary Open Angle Glaucoma and Ocular Hypertension
Qlaris Bio, Inc., a clinical-stage biotechnology company targeting unmet needs in debilitating ophthalmic diseases, today announced positive topline results from two U.S. Phase II clinical trials ...
Atlassian Corporation (TEAM) Q2 2025 Earnings Call Transcript
Good afternoon, and thank you for joining Atlassian's Earnings Conference Call for the Second Quarter of Fiscal Year 2025. As a reminder, this conference call is being recorded and will be available ...